You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid tumors, Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

Not yet recruiting
  • HER2+ Advanced Breast Cancer
  • Other Solid Tumors
  • ADCC-R-Epo-R T-cells + Trastuzumab
  • +2 more
  • (no location specified)
Aug 31, 2023

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)

Not yet recruiting
  • Advanced Breast Cancer
  • Advanced Lung Cancer
  • Tumor-infiltrating lymphocytes
  • IL-2
  • (no location specified)
Oct 26, 2023

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Breast Cancer
  • +4 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Feb 24, 2023

Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Jul 20, 2022

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Fairfax, Virginia
    NEXT Oncology
Jun 7, 2023

Cancer, Breast, Cancer, Lung, Cancer of Pancreas Trial in Fairfax, Beijing (CBP-1019)

Active, not recruiting
  • Cancer, Breast
  • +4 more
  • Fairfax, Virginia
  • +1 more
Apr 13, 2023

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
Has Results
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

Not yet recruiting
  • Advanced Breast Cancer
  • +6 more
  • Providence, Rhode Island
    Lifespan Cancer Institute
Feb 1, 2023

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +8 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Jiangsu, China
    Xuzhou Second People's Hospital
May 8, 2023

Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +9 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Linyi, Shandong, China
    Linyi Central Hospital
Jul 25, 2023

Ovarian Cancer, Melanoma, Triple Negative Breast Cancer Trial (NM1F Injection, Pembrolizumab injection)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • NM1F Injection
  • Pembrolizumab injection
  • (no location specified)
Feb 23, 2023

Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)

Recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Columbus, Ohio
  • +2 more
Jul 26, 2022